Subscribe to Newsletter

"Japanese technologies are among the best in the world - stay informed through our monthly newsletter !

Logo Window to Japan
offers you up-to-date information on Japanese technologies, based on news from Japanese companies, scientific meetings and professional media. The business model of „Window-to-Japan“ is to provide basic information for free including a free monthly newsletter. If you wish to access the much more in-depth information which we continuously retrieve, or if you need customized information, please contact us through the Steinbeis Center Asia Technology Consulting via this website or through

"Window-to-Japan" is a service of Bio4Business, a provider of project support and technology scouting.

15.11 - Otsuka Pharmaceutical erhält FDA-Zulassung für das erste "digitale Medikament" mit Sensor

Otsuka Pharmaceuticals © Proteus Digital HealthOtsuka Pharmaceuticals "digitales" Psychopharmakon

In Otsukas oral eingenommenem Antipsychotikum ABILIFY (Aripipiprazol) ist ein Miniatursensor integriert, der über ein Pflaster erfasst, ob das Medikament überhaupt eingenommen wurde, und mit Zustimmung des Patienten über ein...

© 2017 Window to Japan - Bio 4 Business - Imprint - Terms and Conditions